These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8637403)

  • 1. In vivo labeling of delta opioid receptors in mouse brain by [3H]benzylidenenaltrexone, a ligand selective for the delta 1 subtype.
    Lever JR; Stathis M; Kinter CM; Scheffel U
    Life Sci; 1996; 58(21):PL331-6. PubMed ID: 8637403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective in vivo binding of [3H]naltriben to delta-opioid receptors in mouse brain.
    Lever JR; Scheffel U
    Eur J Pharmacol; 1998 Jun; 350(2-3):335-44. PubMed ID: 9696425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 7-Benzylidenenaltrexone (BNTX): a selective delta 1 opioid receptor antagonist in the mouse spinal cord.
    Sofuoglu M; Portoghese PS; Takemori AE
    Life Sci; 1993; 52(8):769-75. PubMed ID: 8383271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A highly selective delta 1-opioid receptor antagonist: 7-benzylidenenaltrexone.
    Portoghese PS; Sultana M; Nagase H; Takemori AE
    Eur J Pharmacol; 1992 Jul; 218(1):195-6. PubMed ID: 1327826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of delta 1-opioid receptor antagonism in the antitussive effect of delta-opioid receptor antagonists.
    Kamei J; Iwamoto Y; Suzuki T; Misawa M; Nagase H; Kasuya Y
    Eur J Pharmacol; 1994 Jan; 251(2-3):291-4. PubMed ID: 8149982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supraspinal delta receptor subtype activity of heroin and 6-monoacetylmorphine in Swiss Webster mice.
    Rady JJ; Takemori AE; Portoghese PS; Fujimoto JM
    Life Sci; 1994; 55(8):603-9. PubMed ID: 8046996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK; Meert TF
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enkephalin antinociception in mice is mediated by delta 1- and delta 2-opioid receptors in the brain and spinal cord, respectively.
    Takemori AE; Portoghese PS
    Eur J Pharmacol; 1993 Sep; 242(2):145-50. PubMed ID: 8253111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of nociception by microinjection of delta-1 and delta-2 opioid receptor ligands in the ventromedial medulla of the rat.
    Thorat SN; Hammond DL
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1185-92. PubMed ID: 9399992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo binding of N1'-([11C]methyl)naltrindole to delta-opioid receptors in mouse brain.
    Lever JR; Scheffel U; Kinter CM; Ravert HT; Dannals RF; Wagner HN; Frost JJ
    Eur J Pharmacol; 1992 Jun; 216(3):459-60. PubMed ID: 1330587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antinociception and delta-1 opioid receptors in the rat spinal cord: studies with intrathecal 7-benzylidenenaltrexone.
    Hammond DL; Stewart PE; Littell L
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1317-24. PubMed ID: 7562504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological effects of naltriben as a ligand for opioid mu and kappa receptors in rat cerebral cortex.
    Kim KW; Son Y; Shin BS; Cho KP
    Life Sci; 2001 Feb; 68(11):1305-15. PubMed ID: 11233997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of delta 1 and delta 2 opioid receptor subtypes in the development of physical dependence on morphine in mice.
    Suzuki T; Tsuji M; Mori T; Misawa M; Nagase H
    Pharmacol Biochem Behav; 1997; 57(1-2):293-9. PubMed ID: 9164585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Several delta-opioid receptor ligands display no subtype selectivity to the human delta-opioid receptor.
    Parkhill AL; Bidlack JM
    Eur J Pharmacol; 2002 Sep; 451(3):257-64. PubMed ID: 12242086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The design of delta-selective opioid receptor antagonists.
    Portoghese PS
    Farmaco; 1993 Feb; 48(2):243-51. PubMed ID: 8388215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (E)- and (Z)-7-arylidenenaltrexones: synthesis and opioid receptor radioligand displacement assays.
    Palmer RB; Upthagrove AL; Nelson WL
    J Med Chem; 1997 Feb; 40(5):749-53. PubMed ID: 9057861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a highly selective nonpeptide delta opioid receptor agonist, TAN-67, on morphine-induced antinociception in mice.
    Suzuki T; Tsuji M; Mori T; Misawa M; Endoh T; Nagase H
    Life Sci; 1995; 57(2):155-68. PubMed ID: 7603296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of [3H]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: evidence for delta opioid receptor heterogeneity.
    Fang L; Knapp RJ; Horvath R; Matsunaga TO; Haaseth RC; Hruby VJ; Porreca F; Yamamura HI
    J Pharmacol Exp Ther; 1994 Feb; 268(2):836-46. PubMed ID: 8113996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of delta opioid receptors in human brain by N1'-([11C]methyl)naltrindole and PET.
    Madar I; Lever JR; Kinter CM; Scheffel U; Ravert HT; Musachio JL; Mathews WB; Dannals RF; Frost JJ
    Synapse; 1996 Sep; 24(1):19-28. PubMed ID: 9046073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.